Tag: CytoSorbents Corporation
-
South Brunswick’s CytoSorbents authorized to use therapy in patients with severe COVID infections
SOUTH BRUNSWICK – CytoSorbents Corporation, a critical care immunotherapy leader commercializing its CytoSorb blood purification technology to treat cytokine storm and deadly inflammation in critically-ill and cardiac surgery patients around the world, announced the United States Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) of CytoSorb for use in patients with COVID-19…